Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2021-08, Vol.100 (8), p.2117-2119
Hauptverfasser:	Di Prima, Alessio, Botticelli, Andrea, Scalzulli, Emilia, Colafigli, Gioia, Pepe, Sara, Lisi, Chiara, Marchetti, Paolo, Martelli, Maurizio, Foà, Robin, Breccia, Massimo
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - therapeutic use Antineoplastic Agents, Immunological - therapeutic use Carcinoma, Squamous Cell - complications Carcinoma, Squamous Cell - drug therapy Hematology Humans Letter to the Editor Male Medicine Medicine & Public Health Nitriles - therapeutic use Oncology Primary Myelofibrosis - complications Primary Myelofibrosis - drug therapy Protein Kinase Inhibitors - therapeutic use Pyrazoles - therapeutic use Pyrimidines - therapeutic use Skin Neoplasms - complications Skin Neoplasms - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!